14 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
Disclosure Package”), as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary … Writing Prospectus, as supplemented by and taken together with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue
8-K
EX-10.1
n5zsy ic6ygmez
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
bkh3bc3oxjlv
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-1.1
x20a rszrpxx8m4etnw
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-1.1
j6gp4pz 9vw
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
CORRESP
80ck29pu
16 Sep 14
Correspondence with SEC
12:00am
CORRESP
usi b4we209zcsq
1 Jul 14
Correspondence with SEC
12:00am
- Prev
- 1
- Next